Vera Health is a clinician-facing clinical decision-support search engine founded in 2024 by Maxime Allouch and Taieb Bennani, both MIT graduates. It has grown quickly into a broad clinical answer engine, and this review works through what it actually does, what its stronger and weaker points are, and where it sits relative to a UK-native alternative.
The core proposition
Vera Health searches more than 60 million peer-reviewed papers, guidelines and clinical pathways, produces concise clinical answers to a natural-language question, links its key statements directly back to their sources, and applies its own evidence-grading logic before generating a summary, intended to reflect differences in the strength of the underlying literature.
The principal workflows
The platform is organised around several core workflows: differential diagnosis, treatment planning, quick clinical questions answered in a curbside-consult style, dosing and medication checks, an integrated library of clinical calculators, and curated medical research and news.
The access model
Vera Health is free for verified clinicians and trainees, available on web, iOS and Android, and positions itself as an international, multilingual product rather than one restricted to a single country or requiring a specific national identifier to verify access.
Additional features worth reviewing directly
Beyond the core answer engine, Vera Health offers more than 900 integrated calculators, its evidence-grading system, curated medical news, CME credit generated from qualifying searches, and Spaces, a feature allowing clinicians to curate and query a set of team documents and links directly within the platform.
Principal strengths
Several things about the product are genuinely strong. Literature breadth is substantial, drawing on a large, continuously updated corpus. Source linking is fast and transparent, with citations visible alongside the generated answer rather than buried or absent. Its emergency-medicine positioning is particularly credible, reinforced by a formal partnership with the American College of Emergency Physicians covered in detail elsewhere in this cluster. Its free-access model is genuinely generous relative to many competitors that gate access behind institutional subscriptions or national verification requirements. And the mobile experience is well built, with a fast, largely one-handed workflow well suited to ward-based or point-of-care use.
Limitations worth naming directly
Several limitations deserve equally direct treatment. Much of the performance evidence available, including its headline benchmark scores, is company reported rather than independently validated, a point covered in detail elsewhere in this cluster. A large corpus does not automatically guarantee retrieval of the single best source for a given question, since breadth and precision are not the same thing. Evidence grades risk oversimplifying genuinely heterogeneous underlying evidence, collapsing several distinct claims of different certainty into one visible signal. Country-aware or multilingual answers are not the same thing as a deeply UK-specific guideline product built around NICE, CKS and NHS pathways specifically. And, as with any AI-generated clinical answer, clinicians must still independently verify prescribing information and any genuinely high-stakes recommendation before acting on it.
An objective testing protocol worth applying
Before relying on any clinical AI tool, it is worth running it through a structured test rather than a handful of casual queries. A reasonable protocol includes five routine clinical questions representative of everyday practice, five genuinely difficult specialist-level questions, five questions specifically testing UK guideline concordance, three drug-dosing questions where precision matters most, and three questions where the underlying published evidence is known to be genuinely conflicting, testing how the tool handles disagreement rather than simply how it handles consensus.
Where iatroX fits
Vera is genuinely strongest where broad international literature search is the principal requirement, drawing on scale and breadth few competitors can match. iatroX is a UK clinician-founded alternative built around a different priority: NICE, CKS, SIGN, UK medicines information and NHS-specific pathways as the primary lens, with international evidence layered in behind that UK-specific grounding. iatroX also combines clinical search with adaptive question banks, Socratic Tutor, an integrated calculator library, and UK-specific CPD tracking within a single platform.
Best for, less suitable for, and the UK clinician verdict
Vera Health is best for clinicians who need broad, fast, internationally sourced literature search with a genuinely generous free-access model, and it is particularly strong for emergency medicine specifically. It is less suitable as a primary tool for UK clinicians whose day-to-day decisions depend specifically on NICE and CKS concordance rather than general international evidence strength. The UK clinician verdict: Vera Health is a genuinely capable global platform worth having in a broader toolkit, but a UK-native platform such as iatroX remains the more directly useful primary tool for NHS-specific clinical decisions.